【摘 要】
:
目的:观察他汀类药物对行急诊PCI术急性冠状动脉综合征(ACS)患者血脂、高敏C反应蛋白(hs-CRP)及肾功能[血清肌酐(Scr)、肾小球滤过率(eGFR)、尿白蛋白、尿β-2微球蛋白]的影响.
【机 构】
:
徐州市中心医院心内科 苏州大学附属第一医院心内科
【出 处】
:
第二十六届长城国际心脏病学会议、亚太心脏大会2015、国际心血管病预防与康复会议2015
论文部分内容阅读
目的:观察他汀类药物对行急诊PCI术急性冠状动脉综合征(ACS)患者血脂、高敏C反应蛋白(hs-CRP)及肾功能[血清肌酐(Scr)、肾小球滤过率(eGFR)、尿白蛋白、尿β-2微球蛋白]的影响.
其他文献
Peripheral T-cell lymphoma (PTCL) comprises a heterogeneous group of mature T cell tumors with poor prognosis;Allogeneic stem-cell transplantation (allo-SCT) may offer a potential way of cure for thes
Objective Primary central nervous system lymphoma (PCNSL),a rare extranodal form of non-Hodgkin lymphoma (NHL),represents all primary intracerebral or intraocular lymphomas,arising exclusively in the
Objective Primary gastrointestinal lymphoma represents the most frequent subtype of extranodal non-Hodgkins lymphoma and is a heterogeneous group of disorders.Methods To better define the prognostic f
Objectives Defective autophagy is involved in the pathogenesis and progression of lymphoma.Autophagic modulators are promising approaches to improve the therapeutic efficiency and clinical outcome of
Objective Exploration of the pathogenesis of B-cell lymphomas,including mantle cell lymphoma (MCL),has led to the development of new therapeutic strategies.We focused on the B-cell receptor (BCR) sign
Purpose The unity of CA125 as a prognostic tumor marker has not been consistent to date in non-Hodgkins lymphoma (NHL).Furthermore,serous cavity effusion is frequently observed with elevated serum CA1
Introduction Diffuse large B-cell lymphomas (DLBCL) are the most common lymphoid neoplasms but rarely with leukemic phase.Few studies had described the clinical characteristics of DLBCL with leukemic
Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous group of neoplasm with different clinical,immunophenotypic,and genetic abnormalities as well as highly variable prognosis.In this study,we anal
目的:睡眠时间与血脂异常的相关性存在很大争议,中国东北农村地区人群中还未见相关报道,本研究旨在探索中国东北农村地区成人睡眠时间,包括夜间睡眠时间、午睡时间与血脂异常的相关性.
目的:通过比较不同剂量的瑞舒伐他汀对择期行经皮冠状动脉成形术(PCI)的急性冠状动脉综合征(ACS)患者治疗疗效,探讨瑞舒伐他汀减少ACS患者围PCI期心肌损伤发生情况的机制及术后30 d的临床疗效,为择期行PCI术ACS患者应用他汀类药物提供客观依据.